Pre-eclampsia : The Lancet
Links shared publicly online about this topic.
- 1,053total visits
Pre-eclampsia : The Lancet
View full resource at thelancet.com
Tags: Disease and Condition, Doctor, Mortality
Most Recently Shared on July 2, 2010 at 12:47 am By:
RT @TheLancet Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. http://bit.ly/bo1qqk
Infections Cause Many Cancers Globally
medicalnewstoday.com — “A new study published Online First in The Lancet Oncology reveals that from 7.5 million cancer deaths in 2008, about 1.5 million were due to infections that could have either been preve” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2012 at 7:05 pm By:
MNT Infect Diseases Health News
Infections Cause Many Cancers Globally http://t.co/EzKt8m0K #viruses #bacteria
Can Getting Sick Give You Cancer? New Research Says Sometimes, Yes - Forbes
forbes.com — “One sixth of all cases of cancer are caused by viruses and bacteria, new research says. Meaning they're preventable! If we know how.” View full resource at forbes.com
Most Recently Shared on May 11, 2012 at 12:13 am By:
Melanie Haiken, Health Writer Health Advocate
Yikes! Can bacteria and viruses lead to #cancer? New research says yes http://t.co/U9qVin2L via @sharethis @forbes #health #HPV #hepatitis
Protecting Against Serogroup B Meningococcal Strains - New Vaccine Shows Promise
medicalnewstoday.com — “Serogroup B meningococcal strains have become the major cause of bacterial meningitis in many European and North American regions. A new study published Online First in The Lancet Infectiou” View full resource at medicalnewstoday.com
Most Recently Shared on May 10, 2012 at 7:05 pm By:
Protecting Against Serogroup B Meningococcal Strains - New Vaccine Shows Promise http://t.co/gCbKWw2t #vaccines #immunesystem
Infection Behind One Sixth Of Cancers Worldwide
medicalnewstoday.com — “Around 2 million, or one sixth of new cancer cases worldwide are due to infections that are largely preventable or treatable, says a landmark study published in The Lancet Oncology” View full resource at medicalnewstoday.com
Most Recently Shared on May 9, 2012 at 4:05 pm By:
Infection Behind One Sixth Of Cancers Worldwide http://t.co/cgyehRyl #aid
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial : The Lancet
thelancet.com — “Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial. By - Jason D Roberts MD, Prof George A Wells PhD, Prof M...” View full resource at thelancet.com
Most Recently Shared on May 4, 2012 at 7:50 pm By:
[Articles] Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospecti... http://t.co/heUPAiHl
Towards an optimum strategy in rheumatoid arthritis : The Lancet
thelancet.com — “Towards an optimum strategy in rheumatoid arthritis. By - Paul Emery, Maya H Buch” View full resource at thelancet.com
Most Recently Shared on May 4, 2012 at 6:36 pm By:
[Comment] Towards an optimum strategy in rheumatoid arthritis: The outcome for patients with rheumatoid arthriti... http://t.co/aSjoFZef
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial : The Lancet
thelancet.com — “Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. B...” View full resource at thelancet.com
Most Recently Shared on May 4, 2012 at 6:36 pm By:
[Articles] Conventional combination treatment versus biological treatment in methotrexate-refractory early rheum... http://t.co/eQiIWYgz
Minimally Invasive Procedure For Oesophageal Cancer Shows Promise
medicalnewstoday.com — “Patients with oesophageal cancer could gain substantial benefit from minimally invasive procedure.A new study published Online First in The Lancet reveals that removing” View full resource at medicalnewstoday.com
Most Recently Shared on May 1, 2012 at 7:05 pm By:
Minimally Invasive Procedure For Oesophageal Cancer Shows Promise http://t.co/ovC47fO4 #cancer
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial : The Lancet Oncology
thelancet.com — “Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. By - Ravi A Madan MD, Mahsa Mohebtash MD, ...” View full resource at thelancet.com
Most Recently Shared on May 1, 2012 at 5:37 pm By:
[Articles] Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resist... http://t.co/L9G879WO
The STAMPEDE trial and celecoxib: how to adapt? : The Lancet Oncology
thelancet.com — “The STAMPEDE trial and celecoxib: how to adapt?. By - Andrew J Armstrong” View full resource at thelancet.com
Most Recently Shared on May 1, 2012 at 5:37 pm By:
[Comment] The STAMPEDE trial and celecoxib: how to adapt?: In The Lancet Oncology, Nicholas James and colleagues... http://t.co/UZhY4sWj
Social media: how doctors can contribute : The Lancet
thelancet.com — “Social media: how doctors can contribute. By - The Lancet” View full resource at thelancet.com
Most Recently Shared on April 30, 2012 at 2:33 pm By:
Doctors should seize the opportunities provided by social networks to improve the health of their patients http://t.co/kPYIPsca
Social media: how doctors can contribute : The Lancet
nrip.visibli.com — “Social media: how doctors can contribute : The Lancet” View full resource at nrip.visibli.com
Most Recently Shared on April 28, 2012 at 1:00 am By:
Timothy Lomauro Doctor, Psychologist, and PhD
RT @westr: @nrip: Lancet: "Social media: how doctors can contribute" http://t.co/XOHjgqjk #hcsm #pm101 #meded #MCCSM @astupple
The Lancet Technology: April, 2012 : The Lancet
thelancet.com — “The Lancet Technology: April, 2012. By - Niall Boyce” View full resource at thelancet.com
Most Recently Shared on April 27, 2012 at 11:10 pm By:
Ves Dimov, M.D. Internist, Allergist, Physician, and Doctor
Doctors and social media: “How to Stop Worrying and Learn to Love the Internet” http://t.co/JSXBL6QX
Risky Behaviors In Teenagers Should Become Global Focus
medicalnewstoday.com — “According to a report published April 25 by The Lancet, with the global decline of childhood and adolescent mortality from infectious diseases, policymakers are shifting their focus” View full resource at medicalnewstoday.com
Most Recently Shared on April 27, 2012 at 5:05 pm By:
Risky Behaviors In Teenagers Should Become Global Focus http://t.co/ts3gCtot #sexualhealth
Ultra-Long-Acting Insulin Degludec, Two Phase 3 Studies Published
medicalnewstoday.com — “Two Phase III studies, published in The Lancet, reveal that ultra-long-acting insulin degludec considerably reduced rates of nocturnal hypoglycemia in patients with type 1” View full resource at medicalnewstoday.com
Most Recently Shared on April 23, 2012 at 4:05 pm By:
Ultra-Long-Acting Insulin Degludec, Two Phase 3 Studies Published http://t.co/IegXVl9S #diabetes
Advertisement
